|Podcasts|March 19, 2020
Episode 51: Combating Coronavirus
Author(s)Christen Harm, Elaine Quilici
Dr. Eric von Hofe, Chief Scientific Officer at NuGenerex Immuno-Oncology talks about the recent outbreak of Wuhan coronavirus around the world and how biotechs and pharma are jumping in to help find a solution.
Advertisement
Dr. Eric von Hofe, Chief Scientific Officer at NuGenerex Immuno-Oncology talks about the recent outbreak of Wuhan coronavirus around the world and how biotechs and pharma are jumping in to help find a solution.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
The New Healthy Aging Imperative and What It Means for Pharma
3
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
4
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
5